Skip to main content
Download PDF

Med14 cooperates with brg1 in the differentiation of skeletogenic neural crest

BMC Developmental Biology volume 15, Article number: 41 (2015) Cite this article

Abstract

Background

An intricate gene regulatory network drives neural crest migration and differentiation. How epigenetic regulators contribute to this process is just starting to be understood.

Results

We found that mutation of med14 or brg1 in zebrafish embryos resulted in a cluster of neural crest cell-related defects. In med14 or brg1 mutants, neural crest cells that form the jaw skeleton were specified normally and migrated to target sites. However, defects in their subsequent terminal differentiation were evident. Transplantation experiments demonstrated that med14 and brg1 are required directly in neural crest cells. Analysis of med14; brg1 double mutant embryos suggested the existence of a strong genetic interaction between members of the Mediator and BAF complexes.

Conclusions

These results suggest a critical role for Mediator and BAF complex function in neural crest development, and may also clarify the nature of defects in some craniofacial abnormalities.

Background

The neural crest lineage is a multi-potent, migratory population that is unique to vertebrate embryos and gives rise to a diversity of cell types including melanocytes, craniofacial cartilage and bone, smooth muscle, peripheral and enteric neurons and glia [1]. The specification, migration and differentiation of neural crest cells are tightly coordinated during development, with defects in these processes leading to a number of congenital diseases [2]. There is good evidence that during vertebrate embryogenesis a highly conserved neural crest gene regulatory network (GRN) orchestrates transcriptional events that are critical for various steps of neural crest development [3]. In addition to transcriptional regulation, mounting evidence supports a critical role for epigenetic regulation in neural crest development, most notably by controlling the timing of gene expression during this process [4].

Mediator is an evolutionarily conserved, multi-protein complex that is a key regulator of RNA polymerase II-mediated transcription [5]. In metazoan cells, multiple pathways that are responsible for homeostasis, cell growth and differentiation converge on Mediator through transcriptional activators and repressors that target one or more of the 30+ subunits of this complex [6]. Besides RNA polymerase II, Mediator interacts with and coordinates the action of numerous additional transcriptional regulators, including those acting at the level of chromatin remodeling [7, 8]. However, while in vitro data indicates the interaction between Mediator and chromatin remodelers, there is little in vivo data to support this hypothesis. Med14 is a subunit of Mediator that is essential for incorporation of the Tail module into Mediator [6, 9]. We have recently shown that Med14 plays an essential role in vertebrate embryogenesis and stem cell maintenance [10].

Working as a multi-subunit cellular machine that consumes ATP to modify DNA-histone contacts and modulate chromatin compaction, the BAF (BRG1/BRM-associated factors) complex plays a key role in many developmental processes by modulating gene expression. This further occurs via interaction of the BAF complex with transcription factors and other epigenetic readers at promoters and enhancers [11]. The BAF complex includes one of two core ATPases, Brm or Brg1, as well as a number of other subunits. Brm is dispensible for mouse development, whereas Brg1 (Smarca4) is essential for broad aspects of embryogenesis [12, 13]. Differential inclusion of other subunit variants can give novel functions to the BAF complex in processes including neuronal development and cardiogenesis [11, 14, 15]. Reports have demonstrated a role for the Mediator complex in recruitment of the BAF complex to promoters or enhancers of target genes [16, 17], however no in vivo evidence for this genetic interaction and its importance exist to date. Defects in neural crest cell-derived tissues has been noted in brg1 mutants [18] and recent work has shown that the BAF complex co-operates with CHD7 to orchestrate the expression of genes that regulate the migration of neural crest cells [19]. However, the mechanism underlying these roles in neural crest development has to date not been well characterized.

In the present study, we sought to determine the roles of med14 and brg1 during neural crest cells differentiation, and examine any possible genetic interactions. We found that med14 mutant zebrafish embryos demonstrated multiple neural crest cell-related defects. Further analysis indicated that specification and early migration of neural crest cells occurred normally in med14 mutants, with neural crest cells of the jaw subsequently failing to undergo terminal differentiation at their target sites. We further found that mutation of brg1 also resulted in similar abnormalities. Analysis of med14 and brg1 double mutant embryos revealed strong genetic interactions between the Mediator and BAF complexes. Based on transplantation analysis, we found that both med14 and brg1 function in neural crest cells differentiation in a cell-autonomous fashion. Taken together, our results indicate that the BAF and Mediator complexes play essential and overlapping roles in the terminal steps of neural crest differentiation.

Results

In unrelated studies, we noticed that zebrafish log (a null allele for med14) [10] and young (a null allele for brg1) [14] mutants shared a common array of deficiencies in heart, eye, pectoral fin and pigment cell development (Fig. 1a–d and data not shown). This similarity suggested overlapping or common functions for med14 and brg1. To test this possibility, double mutants were generated. The med14; brg1 double mutant embryos displayed a much more severe phenotype compare to single mutants, including a curved body axis, smaller eyes, severe heart edema and loss of pigment (Fig. 1a). To further investigate the role of med14 and brg1 in development, as well as possible functional interactions between the Mediator and BAF complexes, neural crest cell-derived tissues were analyzed in various mutant backgrounds. In med14 and brg1 single mutants, the melanin in melanocytes showed a less even and spiky distribution compared to controls; whereas in med14; brg1 double mutants melanin distribution took on a small, rounded appearance (Fig. 1b–e). Quantification of melanocyte number on the dorsal surface of the trunk revealed no significant differences between controls and mutants (Fig. 1q, P = 0.94).

Fig. 1
figure1

Multiple neural crest-derived phenotypes in mutant embryos. a Images of embryo morphology at 72 hpf. b to e Melanocyte defects in mutants at 48 hpf. Dorsal view with anterior to top. Scale bars, 1 mm. j to p and r to t) Alcian blue staining of cartilage reveals defects in neurocranium and viscerocranium formation in mutant embryos at 96 hpf. At least 15 embryos for each genotype were analyzed and representative samples are showed. Compared to single brg1 or med14 mutants, embryos bearing an additional copy of med14 or brg1 null allele show a more severe phenotype. Ventral view with anterior to the top. bh, basihyal; cb, ceratobranchial; ch, ceratohyal; ep, ethmoid plate; hs, hyosymplectic; m, Meckel’s cartilage; pc, parachordal plate; pq, palatoquadrate; tr, trabeculae. q Quantification of melanocyte number at 48 hpf on the trunks of control and mutant embryos. Twelve embryos for each genotype were counted. Error bars represent the SD

Full size image

The development of the neurocranium and viscerocranium were next analyzed through Alcian blue staining at 96 h post-fertilization (hpf). In brg1 mutants, the neurocranium was dismorphic, and the size of Meckel’s cartilage, ceratohyal and palatoquadrate on the viscerocranium were greatly reduced, with the last two branchial arches absent (Fig. 1j–k and n–o). In med14 mutants, trabeculae formed, while most of the ethmoid plate and lateral parts of parachordal plate were not evident (Fig. 1l). Aside from relics of palatoquadrate, viscerocranium structures were absent in med14 mutants (Fig. 1p). In med14; brg1 double mutants, only posterior portions of trabeculae and parachordal plate were apparent, whereas viscerocranium was completely absent (Fig. 1m). It has been reported some posterior elements (part of trabeculae and parachodal plate) are derived from mesoderm [20]. As these elements remained in med14; brg1 double mutants, this suggested med14 and brg1 are only required for neural crest-derived cartilage.

To further explore genetic interactions between med14 and brg1, we examined cartilage defects in brg1−/−; med14+/− and med14−/−; brg1+/− embryos. In either case, further loss of one allele of med14 or brg1 in either brg1 or med14 null mutants resulted in more severe defects in facial cartilage formation as compared to single mutants (Fig. 1r–t). We also observed that med14 and brg1 mutants shared a common array of deficiencies in heart, eye and otic vesicle development. At 48 hpf, eye, otic vesicle and heart defects in med14 or brg1 mutant embryos were similarly exacerbated in med14/brg1 double mutants (data not shown). Taken together, these data showed that zebrafish med14 or brg1 mutants displayed defects in neural crest-derived cells and tissues such like craniofacial cartilage and melanocyte. Furthermore, med14; brg1 double mutants, or single mutants where one allele of the other gene was lost, displayed a more severe phenotype than single mutants, suggesting overlapping functions of the Mediator and BAF complexes.

As the phenotypes observed in med14 and brg1 mutants involved multiple tissues and developmental stages, we subsequently focused our analysis on jaw cartilage development to uncover the mechanisms of med14 and brg1 function in neural crest development. Neural crest specification was first analyzed via expression of foxd3, sox9b and snail1b, which are expressed in pre-migratory neural crest at the dorsal side of neural tube at 14 hpf [21]. No overt difference in expression was apparent between control and mutant embryos (Fig. 2a–l), indicating that neural crest cells were properly specified in med14, brg1 and med14; brg1 mutants. Subsequent migration of neural crest cells was studied via use of a neural crest-specific sox10:EGFP transgenic line [22]. Neural crest cells in all three mutant backgrounds dispersed and migrated around the eye and optic stalk to reach the oral ectoderm and formed primodia of branchial arches by 24 hpf; with the behavior of neural crest cells being similar between mutant and control embryos (Fig. 3a and d). In situ hybridization also showed that markers of migratory facial neural crest, dlx2a and twist1a, were expressed normally in mutants at 18 hpf (Fig. 3b–c).

Fig. 2
figure2

Neural crest cells are specified normally in mutant embryos. a to l: At 10 somite stage (14 hpf), expression of the neural crest specification markers foxd3, sox9b and snail1b were probed by RNA in situ hybridization. At least 20 embryos for each genotype were analyzed and representative samples are showed. Dorsal views with anterior to the top

Full size image
Fig. 3
figure3

Defects in skeletogenic neural crest differentiation in the jaw forming area of med14 and brg1 mutant embryos. a to d Neural crest cells migrated to the oral ectoderm in both control and mutant embryos. a Snapshot of migrating neural crest cells (marked by sox10:EGFP transgene) in control and mutant embryos at 15 somite stage. b and c The migrating neural crest expressed dlx2a and twist1a at 18 somite stage. d At 24 hpf, neural crest cells reached the brachial arches forming region and condensed. a and d: lateral view with dorsal to top and anterior to left. e to g The mutants showed mis-expression of genes involved in mesenchymal condensations and chondrocyte differentiation. b, c, e, f and g RNA in situ hybridization is shown for expression of dlx2a, tiwst1a, sox9a, dlx3b and hand2. At least 15 embryos for each genotype were analyzed and representative samples are shown. Hollow arrowheads indicate pharyngeal arches; red arrowhead in g indicates the heart tube of embryo. Lateral views with anterior to the left. Scale bars, 100 um

Full size image

To determine if postmigratory cranial neural crest was properly maintained in these mutants, we examined expression of sox9a, dlx3b and hand2, which function in neural crest differentiation [23, 24], at 32 hpf. The expression of sox9a and dlx3b were both down-regulated in med14 and brg1 single mutants, and almost abolished in med14; brg1 double mutants (Fig. 3e–f). At 30 hpf, hand2 clearly marks rings of ventral neural crest in the pharyngeal arches (Fig. 3g). In med14 and brg1 mutant embryos, the expression of hand2 was reduced (Fig. 3g). In med14; brg1 double mutants, the expression was largely abolished except for in a small patch posterior to the eyes, which was maintained. Notably, hand2 expression in the heart tube remained in double mutants, indicating that the regulation of hand2 by brg1 and med14 is neural crest-specific (Fig. 3g). During jaw development, neural crest cells undergo extensive proliferation, so it is possible the defects observed in mutants were due to impaired cell proliferation or enhanced cell death. Cell proliferation and cell death were therefore analyzed at 36 hpf, however no obvious differences between control and mutants was observed (Fig. 4, P = 0.94 for cell proliferation and P = 0.95 for cell death). Taken together, this data suggests that in mutants neural crest cells are formed and migrate properly, but are subsequently unable to initiate a differentiation program towards becoming skeletogenic ectomesenchyme.

Fig. 4
figure4

No apparent alterations in cell proliferation and cell death in arch-forming regions of mutant embryos. a to l Cell proliferation at 36 hpf was analyzed through BrdU incorporation. Neural crest cells were marked by sox10:EGFP transgene and revealed by immunostaining with anti-GFP antibody. Proliferating cells were marked by BrdU then revealed by immunostaining with anti-BrdU antibody. Lateral views with anterior to left. m to t Cell death at 36 hpf was analyzed through TUNEL assay. Lateral views with anterior to left. u Quantification of BrdU-positive cell in 2nd arch (dotted squares in a, d, g and j) in control and mutant embryos. Bars represent the SD. v Quantification of TUNEL positive cell in one side of pharyngeal arches in control and mutant embryos at 36 hpf. Bars represent the SD. Scale bars, 100 um

Full size image

Neural crest differentiation depends both on intrinsic gene regulatory programs and signals from the surrounding environment [25]. As such, deficiencies either in neural crest cells themselves or other tissues could be responsible for the defects we observed in brg1 and med14 mutants and compound mutants. As signals from the endoderm and notochord are indispensable for the migration and differentiation of pharyngeal neural crest cells [26, 27], we first analyzed expression of foxa1 and shh, which are markers of these two tissues, at 30 hpf. Both genes showed apparently normal expression in mutants and compound mutants, suggesting that these tissues were not grossly abnormal (Fig. 5a–d and e–h). Since endodermal pouches play important role in patterning and differentiation of pharyngeal arches [28], we analyzed expression of nkx2.3 and tbx1, which are expressed in both the pre-pouch endoderm and surrounding mesoderm [29]. At 32 hpf, expression of nkx2.3 and tbx1 appeared normal in both wild type and mutant embryos (Fig. 5 i to l and m to p), suggesting that induction of the endodermal pouches is not dependent on med14 or brg1 function.

Fig. 5
figure5

Mesoderm of pharyngeal arches and endodermal pouches are not affected in mutants. a to d: Expression of foxa1 at 32 hpf in pharyngeal endoderm. e to h: The expression of shh in the stomodeum epithelium at 48 hpf. i to l: At 36 hpf, expression of the endodermal pouches marker nkx2.3. m to p: At 36 hpf, expression of the pharyngeal arches mesoderm marker tbx1. a to d and i to l, dorsal view with anterior to the top. e to h and m to p, lateral view with anterior to the left

Full size image

To directly examine the cellular autonomy of med14 and brg1 function, we employed a transplantation approach. Cells were first taken from the animal pole of 4 hpf wild type sox10:EGFP donor embryos and transferred to the equivalent location in wild type or mutant 4 hpf host embryos (Fig. 6a). Based on their localization in the host embryo, a proportion of these naïve cells will normally take on a cranial neural crest fate in these experiments, as indicated by donor cell GFP expression. We observed that in all cases wild type donor GFP-positive neural crest cells in either wild type (n = 33) or mutant (med14−/−: n = 26; brg1−/−: n = 24; med14; brg1 double mutant: n = 11) host embryos migrated to oral ectoderm and formed cartilage clusters, (Fig. 6f–i). Strikingly, as assayed by cartilage staining, we found that wild type donor cells could rescue anterior neurocranium cartilage phenotypes in med14 (43 %, n = 34) and med14; brg1 double mutant embryos (31 %, n = 14) (Fig. 6j–m). When sox10:EGFP activity was compared to cartilage staining results from the same embryos, we observed that anterior neurocranium cartilage entirely matched to GFP-positive clusters (Fig. 6g and k), strongly suggesting that wild type donor cells acted as the source of the cartilage.

Fig. 6
figure6

Wild type neural crest can contribute to jaw cartilage in mutant host. a Schematic diagram of the transplantation approach. Wild type sox10:EGFP transgenic donor cells are transplanted to the animal pole of wild type or mutant host embryos at 4 hpf. b to e At 24 hpf, donor-derived neural crest migration to the oral ectoderm is evident regardless of host genotype. Lateral views with anterior to the top. f to i At 72 hpf, donor-derived neural crest persistence and differentiation to cartilage is evident regardless of host genotype. Ventral views with anterior to the top. j to m At 72 hpf, cartilage staining reveals wild type donor-derived cells partially rescuing anterior neurocranium defects in med14 and med14; brg1 double mutant embryos. g and k represent images from the same embryo. Red arrowheads indicate cartilage derived from wild type donor cells; black arrowheads indicate host cell-derived cartilage. Dorsal views with anterior to the top. Scale bars, 100 um

Full size image

To further examine the fate of med14 and brg1 mutant neural crest cells, transplantation experiments were next carried out in which wild type or mutant sox10:EGFP donor embryos were injected with rhodamine-dextran to allow observation of all donor cells (regardless of neural crest fate) (Fig. 7a). In wild type hosts, GFP-positive single or double brg1 and med14 mutant donor cells were observed that migrated to oral ectoderm at 24 hpf (Fig. 7 c, g, k and o). At 72 hpf, in 54 % of control (wild type donor, n = 44) transplantation experiments, donor cells were observed contributing to cartilage (Fig. 7d–f). In the case of brg1 mutant donor cells, 11 % of transplants showed a contribution to cartilage (n = 31, Fig. 7h–j), with GFP-positive cells displaying abnormal cell shape (compared to the elongated cuboidal shape observed in control transplants (Fig. 7d and h). Strikingly, in none of the transplants where med14 (n = 37) or med14; brg1 (n = 21) mutant donor cells were used was contribution to cartilage noted (based on GFP expression). However, imaging of the donor cell lineage tracer (rhodamine-dextran) showed that mutant cells still survived in the jaw region of wild type hosts (Fig. 7l–n and p–r). These experiments indicated that both med14 and brg1 function cell autonomously in neural crest cells, to govern proper skeletogenic ectomesenchyme differentiation. Further, the persistence of the lineage label in mutant donor cells, despite the absence of cartilage formation, argues for a model where med14 and brg1 are required subsequent to migration of neural crest cells, where they are necessary to the initiation of chondrocyte differentiation. In the absence of this activity, neural crest differentiation to cartilage, and jaw development, is severely perturbed.

Fig. 7
figure7

Cell autonomous requirement for med14 and brg1 in neural crest cells for cartilage differentiation. a Schematic diagram of transplantation approach. Donor (wild type or mutant) sox10:EGFP transgenic embryos were injected with rhodamine-dextran lineage tracer and transplanted to the animal pole of wild type host embryos at 4 hpf. b Diagram showed the region was imaged at 80 hpf. c, g, k and o At 24 hpf, donor-derived neural crest migration to the oral ectoderm is evident regardless of donor genotype. Later views with anterior to the top. d, e and f; h, i and j; l, m and n; p, q and r Donor cell contribution to cartilage assayed at 80 hpf. Ventral views with anterior to the top. D’ and H’: higher magnificent views of regions indicated by red squares in b and e. Scale bars, 100 um

Full size image

Discussion

At different developmental stages, Mediator and BAF complexes influence a wide variety of biological processes. The nature of their activity is context dependent, and in many cases involves differential use of variant complex member subunits to confer different activities [11]. It will be interesting to investigate, specifically in the scenario of neural crest development, how these two complexes function in a tissue and developmental stage specific manner and how the genetic interactions revealed in this study are executed. An intriguing possibility is that subunit(s) of these two complexes act cooperatively to regulate the expression of genes critical for terminal differentiation of craniofacial neural crest cells. As neural crest contributes to a great diversity of additional cell types, and defects were observed in multiple neural crest-derived tissues in med14 and brg1 mutants, more specific analysis of defects in these cell types, and determining which genes are directly regulated by the Mediator and BAF complexes, will be of great interest. Further, while we have described defects in the maintenance of neural crest fate or terminal differentiation in this study, the actual fate of these cells is not clear. Or results suggest these cells are not lost via apoptosis. It will be of interest to determine if they adopt an alternative cell fate, and if so what this fate(s) and what mechanisms underlie this fate conversion may be.

In a previous report [19], knock down of brg1 by morpholino injection in frog embryos led to defects in neural crest migration. Our data, however, suggests that the initial specification and early migration of cranial neural crest occurs normally even in severely affected brg1; med14 double mutants, which is then followed by defects in skeletogenic neural crest differentiation from 30 hpf onwards. Furthermore, by using transplantation approaches, we have shown that med14 and brg1 act cell autonomously (in neural crest) to regulate differentiation of these cells. These discoveries reveal an unexpected mechanism in facial cartilage development, which has been previously ascribed to defects in migration of neural crest cells to the site of differentiation, and raises a possible mechanism underlying the symptoms of neural crest-related diseases, including CHARGE syndrome. It should be noted that these previous studies were largely based on use of morpholino oligonucleotides, whereas our current work uses genetic mutants for analysis. The brg1 mutant used in this study [14] is a strong null allele, and phenocopies other described brg1 mutants [18]. We have recently described three novel med14 mutant alleles [10], with the s231 allele used in this study having an equivalent phenotype to the m628 allele that results in pronounced loss of transcript by nonsense-mediated decay. It is possible the maternally deposited (wild type) Brg1 and Med14 protein or transcript mask early effects on neural crest development in zebrafish mutants. However, as initial neural crest specification and migration appeared roughly normal even in double brg1; med14 mutants, this seems unlikely.

Development of the neural crest is of exceptional medical importance, being affected in a large percentage of congenital defects. The results presented in this study and other recent publications show that the Mediator complex may contribute to a range of neural crest cell-related craniofacial abnormalities. The patients with CHARGE syndrome, a neural crest cell-related congenital anomaly, present a cluster of malformations in craniofacial, peripheral nervous system, ear, eye and heart [30]. Recent work has shown that the BAF complex orchestrates the development of neural crest cells via co-operating with CHD7 [19], which is mutated in the majority of CHARGE syndrome cases [31]. Attempting to identify mutations affecting Mediator complex components in CHARGE syndrome and other neural crest-related patients will be helpful to further illustrate the molecular etiology of these syndromes. A more detailed analysis of mutant models of neural crest-derived craniofacial (and other) defects is also clearly warranted. Generation and analysis of chd7 mutant zebrafish, for example, will be of great interest.

Conclusions

In this study we used genetic tools to analyze the function and interaction of Mediator and BAF complexes on neural crest development. We found that mutation of med14 or brg1 in zebrafish embryos led a cluster of neural crest cell-related defects. Further analysis revealed additive genetic interactions between med14 and brg1, resulting in more severe defects. These defects apparently arise not from an absence of neural crest at the site of cartilage development, but a failure of these cells to properly execute terminal differentiation into jaw cartilage elements. The genetic interaction between brg1 and med14 revealed in this present study indicates that Mediator complex function might act as an additional potential modifier in human congenital jaw defects.

Methods

Zebrafish lines and imaging

Zebrafish embryos were maintained and staged using standard techniques [32]. Tg(sox10:EGFP) ir937, Tg(myl7:EGFP) twu34 and brg1 s481 fish have been previously described [22, 33, 34]. The brg1 s481 allele was identified in a diploid ENU mutagenesis screen for mutations affecting endodermal organ morphogenesis [33]. A C-to-T base-pair change at position 754 in the brg1 (smarca4) coding sequence creates a premature STOP codon at amino acid 252. The med14 s231 allele was first recovered from a screen for cardiovascular mutants [35], and results in a premature STOP codon at amino acid 1200 in the Med14 coding sequence [10]. The s231 allele acts as a null, phenocopying the m628 allele in which mutant transcript levels are greatly reduced by nonsense-mediated decay. Imaging was performed using a Leica DFC320 camera on a Leica M205FA stereomicroscope. All confocal images were taken with Zeiss LSM510 confocal microscope.

RNA probes transcription and RNA in situ hybridization

Transcription of DIG-labeled antisense RNA probes was performed using standard methods. RNA in situ hybridization (ISH) was carried out as previously described [36].

Cartilage staining

Alcian Blue stainng was performed as previously described [37].

Melanocyte counts

At 120 hpf, larvae were incubated in 10 mg/mL epinephrine (diluted in embryo media), anesthetized in tricaine and fixed in 4 % paraformaldehyde at room temperature for 2 h. Larvae were positioned on a spot plate using 3 % methyl cellulose to facilitate counting. Melanophore counts in all experiments included the dorsal (head, trunk and tail) lateral stripes.

Cell proliferation and cell death assays

BrdU incorporation analysis and cell death assay were performed as previously described [38, 39]. Anti-GFP antibody from Abcam was used to label neural crest cells after HCl treatment. Cell death was assayed with a Cell Death Assay Detection Kit, POD (Roche), based on labeling of DNA strand breaks (TUNEL technology).

Transplantation

Transplantation experiments were carried out as previously described [32, 40]. Donor and host embryos were subsequently kept in the same positions in a transplant mold until 48 hpf, when donor genotyping was carried out. For lineage tracing experiments, donor embryos were injected with 2 nl of 5 % tetramethylrhodamine dextran (10,000 MW, Molecular Probes) at the one-cell stage.

Ethics approval

Zebrafish were housed and handled as per Canadian Council on Animal Care and Hospital for Sick Children Laboratory Animal Services guidelines.

Abbreviations

BAF:

BRG1/BRM-associated factors

dpf:

days post-fertilization

GRN:

gene regulatory network

hpf:

hours post-fertilization

NC:

neural crest

References

  1. 1.

    Bronner ME, LaBonne C. Preface: the neural crest--from stem cell formation to migration and differentiation. Dev Biol. 2012;366(1):1.

    CAS  Article  PubMed  Google Scholar 

  2. 2.

    Sauka-Spengler T, Bronner-Fraser M. A gene regulatory network orchestrates neural crest formation. Nat Rev Mol Cell Biol. 2008;9(7):557–68.

    CAS  Article  PubMed  Google Scholar 

  3. 3.

    Betancur P, Bronner-Fraser M, Sauka-Spengler T. Assembling neural crest regulatory circuits into a gene regulatory network. Annu Rev Cell Dev Biol. 2010;26:581–603.

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  4. 4.

    Hu N, Strobl-Mazzulla PH, Bronner ME. Epigenetic regulation in neural crest development. Dev Biol. 2014;396(2):159–68.

    CAS  Article  PubMed  Google Scholar 

  5. 5.

    Myers LC, Kornberg RD. Mediator of transcriptional regulation. Annu Rev Biochem. 2000;69:729–49.

    CAS  Article  PubMed  Google Scholar 

  6. 6.

    Malik S, Roeder RG. The metazoan Mediator co-activator complex as an integrative hub for transcriptional regulation. Nat Rev Genet. 2010;11(11):761–72.

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  7. 7.

    Black JC, Choi JE, Lombardo SR, Carey M. A mechanism for coordinating chromatin modification and preinitiation complex assembly. Mol Cell. 2006;23(6):809–18.

    CAS  Article  PubMed  Google Scholar 

  8. 8.

    Rada-Iglesias A, Bajpai R, Swigut T, Brugmann SA, Flynn RA, Wysocka J. A unique chromatin signature uncovers early developmental enhancers in humans. Nature. 2011;470(7333):279–83.

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  9. 9.

    Grontved L, Madsen MS, Boergesen M, Roeder RG, Mandrup S. MED14 tethers mediator to the N-terminal domain of peroxisome proliferator-activated receptor gamma and is required for full transcriptional activity and adipogenesis. Mol Cell Biol. 2010;30(9):2155–69.

    PubMed Central  Article  PubMed  Google Scholar 

  10. 10.

    Burrows JT, Pearson BJ, Scott IC. An In Vivo Requirement for the Mediator Subunit Med14 in the Maintenance of Stem Cell Populations. Stem Cell Rep. 2015;4(4):670–84.

    CAS  Article  Google Scholar 

  11. 11.

    Ho L, Crabtree GR. Chromatin remodelling during development. Nature. 2010;463(7280):474–84.

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  12. 12.

    Reyes JC, Barra J, Muchardt C, Camus A, Babinet C, Yaniv M. Altered control of cellular proliferation in the absence of mammalian brahma (SNF2alpha). EMBO J. 1998;17(23):6979–91.

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  13. 13.

    Bultman S, Gebuhr T, Yee D, La Mantia C, Nicholson J, Gilliam A, et al. A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes. Mol Cell. 2000;6(6):1287–95.

    CAS  Article  PubMed  Google Scholar 

  14. 14.

    Takeuchi JK, Lou X, Alexander JM, Sugizaki H, Delgado-Olguin P, Holloway AK, et al. Chromatin remodelling complex dosage modulates transcription factor function in heart development. Nat Commun. 2011;2:187.

    PubMed Central  Article  PubMed  Google Scholar 

  15. 15.

    Yoo AS, Staahl BT, Chen L, Crabtree GR. MicroRNA-mediated switching of chromatin-remodelling complexes in neural development. Nature. 2009;460(7255):642–6.

    PubMed Central  CAS  PubMed  Google Scholar 

  16. 16.

    Ansari SA, Paul E, Sommer S, Lieleg C, He Q, Daly AZ, et al. Mediator, TATA-binding protein, and RNA polymerase II contribute to low histone occupancy at active gene promoters in yeast. J Biol Chem. 2014;289(21):14981–95.

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  17. 17.

    Lemieux K, Gaudreau L. Targeting of Swi/Snf to the yeast GAL1 UAS G requires the Mediator, TAF IIs, and RNA polymerase II. EMBO J. 2004;23(20):4040–50.

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  18. 18.

    Eroglu B, Wang G, Tu N, Sun X, Mivechi NF. Critical role of Brg1 member of the SWI/SNF chromatin remodeling complex during neurogenesis and neural crest induction in zebrafish. Dev Dyn. 2006;235(10):2722–35.

    CAS  Article  PubMed  Google Scholar 

  19. 19.

    Bajpai R, Chen DA, Rada-Iglesias A, Zhang J, Xiong Y, Helms J, et al. CHD7 cooperates with PBAF to control multipotent neural crest formation. Nature. 2010;463(7283):958–62.

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  20. 20.

    Kague E, Gallagher M, Burke S, Parsons M, Franz-Odendaal T, Fisher S. Skeletogenic fate of zebrafish cranial and trunk neural crest. PLoS One. 2012;7(11):e47394.

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  21. 21.

    Stuhlmiller TJ, Garcia-Castro MI. Current perspectives of the signaling pathways directing neural crest induction. Cell Mol Life Sci. 2012;69(22):3715–37.

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  22. 22.

    Piloto S, Schilling TF. Ovo1 links Wnt signaling with N-cadherin localization during neural crest migration. Development. 2010;137(12):1981–90.

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  23. 23.

    Yan YL, Miller CT, Nissen RM, Singer A, Liu D, Kirn A, et al. A zebrafish sox9 gene required for cartilage morphogenesis. Development. 2002;129(21):5065–79.

    CAS  PubMed  Google Scholar 

  24. 24.

    Sasaki MM, Nichols JT, Kimmel CB. edn1 and hand2 Interact in early regulation of pharyngeal arch outgrowth during zebrafish development. PLoS One. 2013;8(6):e67522.

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  25. 25.

    Duband JL. Neural crest delamination and migration: integrating regulations of cell interactions, locomotion, survival and fate. Adv Exp Med Biol. 2006;589:45–77.

    CAS  Article  PubMed  Google Scholar 

  26. 26.

    David NB, Saint-Etienne L, Tsang M, Schilling TF, Rosa FM. Requirement for endoderm and FGF3 in ventral head skeleton formation. Development. 2002;129(19):4457–68.

    CAS  PubMed  Google Scholar 

  27. 27.

    Jarov A, Williams KP, Ling LE, Koteliansky VE, Duband JL, Fournier-Thibault C. A dual role for Sonic hedgehog in regulating adhesion and differentiation of neuroepithelial cells. Dev Biol. 2003;261(2):520–36.

    CAS  Article  PubMed  Google Scholar 

  28. 28.

    Graham A, Okabe M, Quinlan R. The role of the endoderm in the development and evolution of the pharyngeal arches. J Anat. 2005;207(5):479–87.

    PubMed Central  Article  PubMed  Google Scholar 

  29. 29.

    Choe CP, Crump JG. Tbx1 controls the morphogenesis of pharyngeal pouch epithelia through mesodermal Wnt11r and Fgf8a. Development. 2014;141(18):3583–93.

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  30. 30.

    Kallen K, Robert E, Mastroiacovo P, Castilla EE, Kallen B. CHARGE Association in newborns: a registry-based study. Teratology. 1999;60(6):334–43.

    CAS  Article  PubMed  Google Scholar 

  31. 31.

    Delahaye A, Sznajer Y, Lyonnet S, Elmaleh-Berges M, Delpierre I, Audollent S, et al. Familial CHARGE syndrome because of CHD7 mutation: clinical intra- and interfamilial variability. Clin Genet. 2007;72(2):112–21.

    CAS  Article  PubMed  Google Scholar 

  32. 32.

    Westerfield M. The Zebrafish Book: A Guide for the Laboratory Use of Zebrafish Danio (Brachydanio) rerio. Oregon: University of Oregon Press; 1993.

    Google Scholar 

  33. 33.

    Ober EA, Verkade H, Field HA, Stainier DY. Mesodermal Wnt2b signalling positively regulates liver specification. Nature. 2006;442(7103):688–91.

    CAS  Article  PubMed  Google Scholar 

  34. 34.

    Huang CJ, Tu CT, Hsiao CD, Hsieh FJ, Tsai HJ. Germ-line transmission of a myocardium-specific GFP transgene reveals critical regulatory elements in the cardiac myosin light chain 2 promoter of zebrafish. Dev Dyn. 2003;228(1):30–40.

    CAS  Article  PubMed  Google Scholar 

  35. 35.

    Jin SW, Herzog W, Santoro MM, Mitchell TS, Frantsve J, Jungblut B, et al. A transgene-assisted genetic screen identifies essential regulators of vascular development in vertebrate embryos. Dev Biol. 2007;307(1):29–42.

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  36. 36.

    Thisse C, Thisse B. High-resolution in situ hybridization to whole-mount zebrafish embryos. Nat Protoc. 2008;3(1):59–69.

    CAS  Article  PubMed  Google Scholar 

  37. 37.

    Klymkowsky MW, Hanken J. Whole-mount staining of Xenopus and other vertebrates. Methods Cell Biol. 1991;36:419–41.

    CAS  Article  PubMed  Google Scholar 

  38. 38.

    Caron SJ, Prober D, Choy M, Schier AF. In vivo birthdating by BAPTISM reveals that trigeminal sensory neuron diversity depends on early neurogenesis. Development. 2008;135(19):3259–69.

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  39. 39.

    Verduzco D, Amatruda JF. Analysis of cell proliferation, senescence, and cell death in zebrafish embryos. Methods Cell Biol. 2011;101:19–38.

    CAS  Article  PubMed  Google Scholar 

  40. 40.

    Scott IC, Masri B, D’Amico LA, Jin SW, Jungblut B, Wehman A, et al. The G-Protein Coupled Receptor Agtrl1b Regulates Early Development of Myocardial Progenitors. Dev Cell. 2007;12(3):403–13.

    CAS  Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Thomas F. Schilling for the kind gift of Tg(sox10:eGFP) ir937 zebrafish, Sarah Hutchinson for discussion and sharing protocols, Angela Morley for zebrafish husbandry and members of the Scott lab for feedback and help during this project. This research was undertaken, in part, thanks to fellowship funding from the Heart & Stroke/Richard Lewar Centre of Excellence at the University of Toronto and the Hospital for Sick Children Research Institute (to X.L.) and grant funding from the Natural Sciences and Engineering Research Council of Canada (RGPIN 341545 to I.C.S.) and National Natural Science Foundation of China (NSFC 31471354 to X.L.).

Author information

Affiliations

  1. Model Animal Research Center, Nanjing University, 12 Xuefu Road, Nanjing, 210061, Jiangsu, China

    Xin Lou

  2. Program in Developmental and Stem Cell Biology, The Hospital for Sick Children, 686 Bay Street, Toronto, Ontario, M5G 0A4, Canada

    Xin Lou, Jeffrey T. A. Burrows & Ian C. Scott

  3. Department of Molecular Genetics, University of Toronto, 1 King‚s College Circle, Toronto, M5S 1A8, Ontario, Canada

    Xin Lou, Jeffrey T. A. Burrows & Ian C. Scott

  4. Heart & Stroke/Richard Lewar Centre of Excellence, University of Toronto, 101 College Street, Toronto, M5G 1L7, Ontario, Canada

    Xin Lou & Ian C. Scott

Authors
  1. Xin Lou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jeffrey T. A. Burrows
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ian C. Scott
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Xin Lou or Ian C. Scott.

Additional information

Competing interests

The authors declare no competing financial interests.

Authors’ contributions

XL and ICS conceived the project and wrote the manuscript. XL and JB performed all experiments. ICS supervised the project. All authors have read and approved the manuscript.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Lou, X., Burrows, J.T.A. & Scott, I.C. Med14 cooperates with brg1 in the differentiation of skeletogenic neural crest. BMC Dev Biol 15, 41 (2015). https://doi.org/10.1186/s12861-015-0090-9

Download citation

Keywords

  • Neural crest
  • Mediator complex
  • BAF complex
  • Brg1
  • Craniofacial defect
  • Med14
  • Jaw development

BMC Developmental Biology

ISSN: 1471-213X

Contact us